Calcyphosine 抗体 (AA 101-189) (AbBy Fluor® 594)
-
- 抗原 See all Calcyphosine (CAPS) 抗体
- Calcyphosine (CAPS)
-
抗原表位
- AA 101-189
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Calcyphosine antibody is conjugated to AbBy Fluor® 594
-
应用范围
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 交叉反应
- 人
- 预测反应
- Dog,Cow,Sheep,Pig,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human Calcyphosine 1
- 亚型
- IgG
- Top Product
- Discover our top product CAPS Primary Antibody
-
-
- 应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- Calcyphosine (CAPS)
- 别名
- Calcyphosine 1/CAPS1 (CAPS 产品)
- 别名
- CAPS1 antibody, Caps antibody, Caps1 antibody, Caps2 antibody, caps1 antibody, MGC84373 antibody, CAPS antibody, calcyphosine antibody, calcium dependent secretion activator antibody, calcyphosine S homeolog antibody, CAPS antibody, Cadps antibody, caps.S antibody, caps antibody, Caps antibody
- 背景
-
Synonyms: Calcyphosin, Calcyphosine 1, Calcyphosine, CAPS, CAPS1, CAYP1_HUMAN, Thyroid protein p24.
Background: CAPS1 is a 189 amino acid cytoplasmic protein that contains four EF-hand domains, which serve as calcium-binding sites, and was first identified in canine thyroid. Interestingly, CAPS1 is much less abundant in humans than in canines. Synthesis and phosphorylation of CAPS1 is upregulated by cAMP-agonists in thyrocytes. CAPS1 likely functions in the regulation of ionic transport and may be involved in cross-signaling between cAMP and Ca(+2)-phophatidylinositol cascades. In addition to thyriod, CAPS1 is expressed in brain, salivary glands and lung. Expression of CAPS1 is increased in endometrial cancer and prognosis seems to be dependent on the level of CAPS1 expression, indicating that CAPS1 may be an appropriate prognostic marker for patient survival.
-